Most Favored Nation – Free-Market Opposition
Read what others have to say:
Tomas Philipson: Pharmaceutical Trade Imbalance: America Subsidizing Medicine Prices
Wayne Winegarden: Trump Should Support Effective Drug Policy Reforms Not The MFN Gimmick
Merrill Matthews: Trump’s Proposal for Price Controls Faces Criticism Again
Sally Pipes: Medicaid Is Not A Test Lab For Foreign Price Controls
Wayne Winegarden: Congress Should Not Impose Foreign Price Controls On Innovative Drugs
Ryan Ellis: Conservatives Must Resist the Temptation of European Drug Price Controls
Sally Pipes: Price Controls Won’t End Global Pharma Freeloading
Sally Pipes: Trump’s ‘Most Favored Nation’ Drug Plan Doesn’t Favor Americans
Sally Pipes: A Most Flawed Notion: Medicaid ‘Fix’ Will Worsen 340B Crisis
Christina Smith: Most favored nation is a destructive price control
American Commitment: Trump Should Take Aim at Foreign Freeloading on Prescription Drugs
Pete Sepp: Warning from Economists: Drug Price Controls Will Harm Taxpayers
Isabelle Morales: Drug Pricing Executive Order Addresses a Real Problem with the Wrong Solution
Justin Leventhal: ‘Most Favored Nation’ Price Controls Are the Path to Drug Shortages
Kimberly Strassel: Republicans for Price Controls
Michael Baker: Most Favored Nation Drug Pricing: Inviting Unnecessary Harm Upon American Patients
Douglas Holtz-Eakin: Out of the Frying Pan
Deroy Murdock: Pharmacy Benefit Manager Parasites Drive Drug Costs Ever Higher
Kent Kaiser: Trump Policy Threatens Biomedical Innovation
CASM: New Poll Reveals Voters’ Concerns with Implementing a “Most Favored Nation” Drug Pricing Model
Drew Johnson: Trump Can Lower Drug Prices By Fixing The Market
Richard Burr: The Drug-Price Surrender to China